FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief

The U.S. Food and Drug Administration approved the first new pain reliever to hit the market in over 20 years. This medication, produced by Vertex Pharmaceuticals Inc VRTX +0.07% , is a non-opioid and therefore non-addictive. The new drug, suzetrigine, will be sold under the brand name Journavx.

Unlike opioids, Journavx blocks pain signals in the peripheral nervous system, not in the brain, so it does not create the same pleasurable effects usually felt with opioids and which often leads to dependence or addiction.

Buzz

At 420 Intel, we cover cannabis legalization news throughout the world, offer reliable information for cannabis business owners, detail technological advances that impact the marijuana industry, cover marijuana rallies from across the globe, and everything in between.

Press ESC to close

FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief

Buzz

5 Reasons to Consider Medicinal Cannabis for Pain

Chronic Pain Patients Support Cannabis Access Expansion While Physicians Favor Restrictions, Study Finds

People suffering from chronic pain are more supportive of policies that expand cannabis access as...

Review of Studies on Cannabis for Neuropathic Pain

Researchers analyzed studies from the past two decades on the impact of cannabinoids on neuropathic...